6-glucosyl-apigenin,
6-glucosylapigenin,
apigenin 6-C-glucoside,
isovitexin,
Isovitexin,
Saponaretin,
Homovitexin,
38953-85-4,
29702-25-8,
Apigenin-6-C-glucoside,
6-Glucosylapigenin,
6-C-Glucosylapigenin,
UNII-KTQ9R9MS0Q,
ISOVITEXIN WITH,
Apigenin 6-C-glucoside,
KTQ9R9MS0Q,
CHEBI:18330,
4H-1-Benzopyran-4-one, 6-beta-D-glucopyranosyl-5,7-dihydroxy-2-(4-hydroxyphenyl)-,
Isoavroside,
(1S)-1,5-anhydro-1-[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-6-yl]-D-glucitol,
SMR001215816,
CCRIS 9341,
beta-D-isovitexin,
Apigenin 6-C-beta-glucopyranoside,
Isovitexin with HPLC,
AC1Q6BBK,
C01714,
AC1L4R4R,
MLS000563041,
MLS002473147,
SCHEMBL513620,
Isovitexin, analytical standard,
CHEMBL465360,
Flavone, 6-beta-D-glucopyranosyl-4',5,7-trihydroxy-,
MYXNWGACZJSMBT-VJXVFPJBSA-N,
HMS2268O04,
HY-N0773,
Isovitexin, >=98.0% (HPLC),
ZINC4095704,
MFCD00076044,
AKOS032948364,
CCG-208397,
6-b-d-glucopyranosyl-5,7-dihydroxy-2-(4-hydroxyphenyl)-4h-1-benzopyran-4-one,
6-beta-D-Glucopyranosyl-5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one,
NCGC00163578-01,
4CN-1176,
CS-0009796,
FT-0645081,
FT-0686646,
W1628,
A12079,
Isovitexin, primary pharmaceutical reference standard,
Flavone, 6-.beta.-D-glucopyranosyl-4',5,7-trihydroxy-,
4H-1-Benzopyran-4-one, 6-.beta.-D-glucopyranosyl-5,7-dihydroxy-2-(4-hydroxyphenyl)-,
4H-1-Benzopyran-4-one, 6-beta-D-glucopyranosyl-5,7-dihydroxy-2-(4-hydroxyphenyl)- (VAN),
4H-1-Benzopyran-4-one,6-b-D-glucopyranosyl-5,7-dihydroxy-2-(4-hydroxyphenyl)-,
5,7-dihydroxy-2-(4-hydroxyphenyl)-6-((2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)-4H-chromen-4-one,
5,7-dihydroxy-2-(4-hydroxyphenyl)-6-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]chromen-4-one,
5,7-dihydroxy-2-(4-hydroxyphenyl)-6-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]chromen-4-one,
AR-1H0977,
AR-1H0978,
C21H20O10,
CID162350,
ACN-047124,
C21-H20-O10,
509-24-0,
50928-80-8,